HERITAGE & OVERVIEW
Department Overview & Heritage
National Leading Hospital of the National Rare Disease Diagnosis and Treatment Collaboration Network, host of the National Rare Disease Registration Platform (over 40,000 cases registered in-depth). Chief editor of China's first 'Guidelines for the Diagnosis and Treatment of Rare Diseases'. In February 2024, the first independent specialized ward for rare diseases will be officially launched, with 34 MDT specialty groups for complex diseases, serving as a core national base to address the challenges of 'difficult access to care, difficult diagnosis, and difficult medication'.
With the spirit of 'Centennial Grand Ward Rounds', relying on 34 MDT expert groups, the rare disease specialized ward, and national key laboratories, we achieve a complete loop of 'clinical discovery—gene decoding—basic analysis—targeted therapy'.
Century-Old Heritage · Premier Specialties
Academic Standing & Clinical Excellence
National Leading Hospital of the National Rare Disease Diagnosis and Treatment Collaboration Network, host of the National Rare Disease Registration Platform (over 40,000 cases registered in-depth). Chief editor of China's first 'Guidelines for the Diagnosis and Treatment of Rare Diseases'. In February 2024, the first independent specialized ward for rare diseases will be officially launched, with 34 MDT specialty groups for complex diseases, serving as a core national base to address the challenges of 'difficult access to care, difficult diagnosis, and difficult medication'.
📍 Clinical Campuses:Dongdan Campus (Main Campus)
CLINICAL SCOPE
Core Indications & Conditions Treated
01Complex undiagnosed diseases with unclear diagnosis (patients who have been to multiple hospitals without a diagnosis for a long time)
02Single-gene rare diseases and hereditary metabolic disorders affecting multiple systems
03POEMS syndrome, Castleman disease, and autoinflammatory diseases
04Lymphangioleiomyomatosis (LAM), idiopathic pulmonary fibrosis, and other rare respiratory diseases
05Fabry disease, Pompe disease, mucopolysaccharidosis, and other lysosomal storage disorders
06Transthyretin amyloidosis (ATTR) cardiomyopathy/multiple neuropathy
07Osteogenesis imperfecta (brittle bone disease), achondroplasia, and other rare bone metabolic disorders
08Hereditary angioedema (HAE), neuromyelitis optica, and other immune-related rare diseases
EXCELLENCE IN CARE
Clinical Strengths & Advanced Capabilities
With the spirit of 'Centennial Grand Ward Rounds', relying on 34 MDT expert groups, the rare disease specialized ward, and national key laboratories, we achieve a complete loop of 'clinical discovery—gene decoding—basic analysis—targeted therapy'.
1
Multidisciplinary one-stop care in the independent specialized ward for rare diseases: daily joint ward rounds and interdisciplinary consultations by renowned experts from multiple specialties
2
Rapid molecular genetic etiology screening channels using whole exome sequencing (WES) and whole genome sequencing (WGS)
3
National rare disease registration system and multicenter clinical follow-up network, driving clinical trials for new drugs for rare diseases and synchronized international market entry
4
'Orphan drug' precise medication rapid green approval and long-term multidisciplinary comprehensive functional rehabilitation assessment
5
34 outpatient MDT specialty groups for complex diseases (covering pituitary, pancreas, musculoskeletal, cardiovascular, thoracic tumors, etc.), serving tens of thousands of patients